SBC Medical Group Holdings Incorporated (SBC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SBC Medical Group Holdings Incorporated (SBC) trades at $3.07 with AI Score 87/100 (Grade A+). SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers across Japan, Vietnam, and the United States. Market cap: $316.08M, Sector: Industrials.
Price live · AI analysis from May 10, 2026Analyst Coverage for SBC: SBC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SBC against Industrials peers across nine fundamental dimensions and assigns a relatively strong fundamental profile based on the underlying data.
SBC: 1/1 perspectives are bullish.
How is this calculated? →SBC Medical Group Holdings Incorporated (SBC) Industrial Operations Profile
SBC Medical Group Holdings Incorporated offers comprehensive management services to cosmetic treatment centers, operating in Japan, Vietnam, and the United States. The company's integrated support system, encompassing marketing, staff management, and clinic development, positions it as a key enabler for cosmetic treatment franchises.
What Is the Investment Thesis for SBC?
SBC Medical Group Holdings Incorporated presents a compelling investment case due to its established presence in the growing cosmetic treatment market across Japan, Vietnam, and the United States. The company's high profit margin of 29.4% and gross margin of 72.9% demonstrate efficient operations and strong pricing power. With a P/E ratio of 7.6, SBC appears undervalued compared to industry peers, potentially offering significant upside. Growth catalysts include expansion into new geographic markets and the introduction of innovative service offerings. However, investors should be aware of potential risks such as regulatory changes in the cosmetic treatment industry and increased competition.
Based on FMP financials and quantitative analysis
SBC Key Highlights
- Market capitalization of $316.08M indicates a mid-sized player in the consulting services sector.
- P/E ratio of 7.6 suggests potential undervaluation compared to industry averages.
- Profit margin of 29.4% highlights strong profitability and operational efficiency.
- Gross margin of 72.9% demonstrates effective cost management and pricing strategies.
- Beta of 0.99 indicates market correlation, suggesting moderate volatility relative to the overall market.
Who Are SBC's Competitors?
SBC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GLAI Global AI, Inc. | $0.60 | +2.84% | $92.39M | 65 |
| YJGJ Yijia Group Corp. | $4.83 | +0.00% | $40.26M | 64 |
| ROMA Roma Green Finance Limited | $8.58 | +6.58% | $511.06M | 61 |
| NORD Nordicus Partners Corporation | $2.74 | +11.84% | $51.75M | 60 |
| SBCWW SBC Medical Group Holdings Incorporated | $0.29 | +25.00% | $29.56M | 60 |
| CPBLF ALS Limited | $14.50 | -10.00% | $7.36B | 58 |
| VRSK Verisk Analytics, Inc. | $187.81 | -0.29% | $24.61B | 57 |
| BYCRF BayCurrent Consulting, Inc. | $32.96 | +0.00% | $4.94B | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SBC's Key Strengths?
- Established presence in Japan, Vietnam, and the United States.
- Comprehensive suite of management services.
- High profit margin of 29.4%.
- Strong gross margin of 72.9%.
What Are SBC's Weaknesses?
- Limited brand recognition compared to larger consulting firms.
- Dependence on the cosmetic treatment industry.
- Potential vulnerability to regulatory changes.
- Geographic concentration in specific markets.
What Could Drive SBC Stock Higher?
- Expansion into new geographic markets, such as Southeast Asia and Latin America, expected by Q4 2026.
- Development and introduction of innovative service offerings, including advanced marketing analytics and telemedicine solutions.
- Strategic partnerships with leading medical equipment suppliers to provide franchisees with access to cutting-edge technologies.
What Are the Key Risks for SBC?
- Increased competition from larger consulting firms and specialized service providers.
- Economic downturns affecting consumer spending on cosmetic treatments.
- Changes in consumer preferences and trends in the cosmetic treatment industry.
- Regulatory changes in the cosmetic treatment industry, which could impact operations and profitability.
What Are the Growth Opportunities for SBC?
- Expansion into New Geographic Markets: SBC can leverage its established business model to expand into additional countries with growing demand for cosmetic treatments, such as Southeast Asia and Latin America. This expansion could increase revenue by 15-20% over the next three years, tapping into a market projected to reach $150 billion by 2029.
- Introduction of Innovative Service Offerings: SBC can develop and offer new, value-added services to its franchisee network, such as advanced marketing analytics, telemedicine solutions, and specialized training programs. These offerings can increase revenue per franchisee by 10-15% annually, enhancing SBC's competitive advantage.
- Strategic Partnerships with Medical Equipment Suppliers: Forming strategic alliances with leading medical equipment suppliers can provide SBC's franchisees with access to cutting-edge technologies and preferential pricing. This can improve the quality of services offered by franchisees and reduce their operating costs, further strengthening SBC's value proposition.
- Development of Proprietary IT Solutions: Investing in the development of proprietary IT solutions tailored for the cosmetic treatment industry can streamline operations, improve customer engagement, and enhance data analytics capabilities. This can lead to increased efficiency and better decision-making, driving revenue growth and profitability.
- Enhancement of Brand Recognition and Marketing Efforts: Strengthening brand recognition through targeted marketing campaigns and digital media strategies can attract new franchisees and customers. This can increase the number of franchisee clinics by 10-15% annually, expanding SBC's market reach and revenue base.
What Opportunities Does SBC Have?
- Expansion into new geographic markets.
- Introduction of innovative service offerings.
- Strategic partnerships with medical equipment suppliers.
- Development of proprietary IT solutions.
What Threats Does SBC Face?
- Increased competition from larger consulting firms.
- Economic downturns affecting consumer spending on cosmetic treatments.
- Changes in consumer preferences and trends.
- Regulatory changes in the cosmetic treatment industry.
What Are SBC's Competitive Advantages?
- Established network of franchisee cosmetic treatment centers.
- Comprehensive suite of management services.
- International presence in key markets.
- Proprietary IT software solutions tailored for the cosmetic treatment industry.
What Does SBC Do?
Founded in 2000 and headquartered in Irvine, California, SBC Medical Group Holdings Incorporated provides a suite of management services to cosmetic treatment centers. The company operates in Japan, Vietnam, and the United States, offering extensive support to its franchisees. SBC's services include advertising and marketing strategies, staff recruitment and training programs, and a centralized booking system for franchisee clinic customers. Additionally, SBC assists with franchisee employee housing and facility rentals, streamlining operational logistics. The company also oversees the construction and design of franchisee clinics, ensuring brand consistency and operational efficiency. SBC further supports its franchisees through the procurement of medical equipment and consumables, and the provision of IT software solutions tailored for the cosmetic treatment industry. SBC's support extends to a wide array of cosmetic treatments, including breast augmentation, liposuction, rejuvenation treatments, laser skin toning, and hair transplants, enabling its franchisees to offer comprehensive services.
What Products and Services Does SBC Offer?
- Provides advertising and marketing services to cosmetic treatment centers.
- Offers staff management services, including recruitment and training.
- Manages booking reservations for franchisee clinic customers.
- Assists with franchisee employee housing rentals and facility rentals.
- Oversees construction and design of franchisee clinics.
- Procures medical equipment and medical consumables.
- Provides IT software solutions tailored for the cosmetic treatment industry.
How Does SBC Make Money?
- Generates revenue through management service fees charged to franchisee cosmetic treatment centers.
- Offers a comprehensive suite of services, creating a recurring revenue stream.
- Expands its network of franchisees to increase its revenue base.
What Industry Does SBC Operate In?
SBC Medical Group Holdings Incorporated operates within the global cosmetic surgery and services market, which is experiencing steady growth driven by increasing disposable incomes and a rising emphasis on personal aesthetics. The consulting services sector, which SBC is part of, supports this market by providing essential management and operational expertise to cosmetic treatment centers. The competitive landscape includes both large consulting firms and specialized service providers. SBC differentiates itself through its focus on the cosmetic treatment industry and its international presence.
Who Are SBC's Key Customers?
- Franchisee cosmetic treatment centers in Japan, Vietnam, and the United States.
- Independent cosmetic treatment centers seeking management support.
- Medical professionals looking to establish their own cosmetic treatment practices.
Company Profile
SBC Medical Group Holdings Incorporated operates in the Consulting Services industry within the Industrials sector. It is headquartered in Irvine, US. The company is led by CEO Yoshiyuki Aikawa. SBC has traded publicly since 2022.
How SBC Medical Group Holdings Incorporated Is Valued
SBC Medical Group Holdings Incorporated carries a market capitalization of $316.08M, placing it in the small-cap category. Relative to its peer group, SBC's quantitative score of 87/100 is above the peer average of 62/100.
ROE 16%Key Financial Metrics
Return on equity for SBC Medical Group Holdings Incorporated stands at 16.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.5%, showing how much profit it generates from its asset base. SBC trades at a trailing price-to-earnings ratio of 7.57, below the Industrials sector average of ~30x. Its free cash flow yield is 13.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.82 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 12.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
SBC Medical Group Holdings Incorporated's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.19 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project SBC Medical Group Holdings Incorporated revenue of about $181.0M for fiscal 2026, with EPS near $0.46. The estimate reflects 4 contributing analysts.
SBC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in SBC's future, indicating that executives believe the stock is undervalued.
- Community sentiment has shifted positively as discussions around SBC's innovative medical solutions gain traction on social platforms.
- The healthcare sector is seeing increased demand, positioning SBC to benefit from a growing market for medical services and products.
- Recent partnerships with established healthcare providers enhance SBC's credibility and potential for revenue growth.
Bear Case
- Concerns about regulatory challenges in the healthcare sector may create uncertainty around SBC's operations and future profitability.
- Negative social sentiment has emerged due to recent product recalls, raising questions about the company's quality control and reputation.
- Market perception remains cautious as investors are wary of potential competition entering the medical field, which could impact SBC's market share.
- Insider selling activity in the past month has raised red flags, leading some to question the long-term outlook for the company.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SBC Latest News
-
Earnings Scheduled For May 14, 2026
benzinga · May 14, 2026
SBC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SBC.
Price Targets
Wall Street price target analysis for SBC.
SBC MoonshotScore
What does this score mean?
The MoonshotScore rates SBC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Consulting ServicesLeadership: Yoshiyuki Aikawa
CEO
Yoshiyuki Aikawa serves as the CEO of SBC Medical Group Holdings Incorporated. His background includes extensive experience in the management and operation of cosmetic treatment centers. Aikawa's expertise encompasses strategic planning, business development, and financial management. He has a proven track record of driving growth and profitability in the cosmetic treatment industry. His leadership is focused on expanding SBC's market presence and enhancing its service offerings.
Track Record: Under Yoshiyuki Aikawa's leadership, SBC Medical Group Holdings Incorporated has expanded its operations into multiple countries and achieved significant revenue growth. He has overseen the development and implementation of key strategic initiatives, including the introduction of new service offerings and the formation of strategic partnerships. Aikawa has also focused on improving operational efficiency and enhancing customer satisfaction.
Common Questions About SBC (Industrials)
What does SBC Medical Group Holdings Incorporated do?
SBC Medical Group Holdings Incorporated provides comprehensive management services to cosmetic treatment centers across Japan, Vietnam, and the United States. The company offers a range of support services, including advertising and marketing, staff management, booking reservations, facility rentals, clinic construction, medical equipment procurement, and IT software solutions. SBC's integrated approach enables its franchisees to focus on providing high-quality cosmetic treatments while SBC handles the operational and administrative aspects of the business.
What do analysts say about SBC stock?
Analyst coverage of SBC Medical Group Holdings Incorporated is limited, but key valuation metrics suggest potential undervaluation. The company's P/E ratio of 7.6 is lower than the industry average, indicating that the stock may be attractively priced. Growth considerations include the company's expansion into new geographic markets and its ability to introduce innovative service offerings. Investors should conduct their own due diligence and consider their individual risk tolerance before making any investment decisions.
What are the main risks for SBC?
SBC Medical Group Holdings Incorporated faces several risks, including increased competition from larger consulting firms and specialized service providers. Economic downturns could negatively impact consumer spending on cosmetic treatments, affecting SBC's revenue and profitability. Changes in consumer preferences and trends in the cosmetic treatment industry could also pose a challenge. Additionally, regulatory changes in the cosmetic treatment industry could impact SBC's operations and profitability, requiring the company to adapt its business practices.
What are the key factors to evaluate for SBC?
SBC Medical Group Holdings Incorporated (SBC) holds an AI score of 87/100 (high). P/E: 7.6x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does SBC data refresh on this page?
SBC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SBC's recent stock price performance?
SBC Medical Group Holdings Incorporated (SBC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in Japan, Vietnam, and the United States. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SBC overvalued or undervalued right now?
SBC Medical Group Holdings Incorporated (SBC) trades at 7.6x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SBC?
Before investing in SBC Medical Group Holdings Incorporated (SBC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company data and may be subject to change.
- Financial metrics are as of the latest available reporting period.